Assessing resource allocation and exploring measures to promote human papillomavirus vaccination in Beijing, China
Open Access
- 3 November 2026
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1)
Abstract
Human papillomavirus (HPV) infection is the primary cause of nearly all cervical cancers and a significant contributor to oropharyngeal, anal, and genital cancers. The global health burden of cervi...Keywords
Funding Information
- Beijing Municipal Health Commission (Discipline Core-03-36)
This publication has 26 references indexed in Scilit:
- Global HPV vaccination programs and coverage rates: a systematic revieweClinicalMedicine, 2025
- Balancing fairness and efficiency in dynamic vaccine allocation during major infectious disease outbreaksScientific Reports, 2025
- Epidemiology of HPV-associated cancers past, present and future: towards prevention and eliminationNature Reviews Clinical Oncology, 2024
- Evaluating the accessibility and capacity of SARS-CoV-2 vaccination and analyzing convenience-related factors during the Omicron variant epidemic in Beijing, ChinaHuman Vaccines & Immunotherapeutics, 2023
- Global and regional estimates of cervical cancer burden associated with human immunodeficiency virus infection from 1990 to 2019Journal of Medical Virology, 2023
- Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination InitiativeThe Lancet Global Health, 2022
- Cancer incidence and mortality in China, 2016Journal of the National Cancer Center, 2022
- Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptakeVaccine, 2021
- Preference and willingness to pay of female college students for human papillomavirus vaccination in Zhejiang Province, China: A discrete choice experimentHuman Vaccines & Immunotherapeutics, 2021
- A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland ChinaVaccine, 2021